Bayer Cropscience Ltd Share Price & Stock Analysis

Bayer Cropscience Ltd (BSE: 506285) is a Thane, Maharashtra-based company in the Crop Protection Chemicals industry. With a market capitalisation of ₹15,609 Cr, it ranks #448 by market cap among the 6,197 Indian listed companies on FinBizNet, and #4 of 45 in Crop Protection Chemicals. At ₹3,450.00 (as of 16 Nov 2026), the share price is 31.9% below its 52-week high of ₹5,063.00 and 6.9% above its 52-week low of ₹3,226.10. The share price is down 24.9% over one year and down 15.6% over three months.

Key Metrics

Current Price₹3,450.00
Market Cap₹15,609 Cr
BSE Code506285
SectorMaterials > Chemicals > Fertilizers & Agri Chemicals
Sub-IndustryFertilizers and Agricultural Chemicals > Crop Protection Chemicals
P/E Ratio22.7
Return on Equity23.70%
Return on Assets8.91%
52-Week Range₹3,226.10 – ₹5,063.00
1-Year Price Change-24.9%
3-Month Price Change-15.6%
Beta (1Y)0.16
Dividend Yield3.45%
HeadquartersThane, Maharashtra
Websitewww.bayer.in

Latest Quarterly Results — Q1 FY27

Revenue₹1,835 Cr
Net Profit₹322 Cr
Net Margin17.5%
EPS (Basic)₹71.56
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Bayer Cropscience Ltd Quarterly Revenue and Profit Trend

Bayer Cropscience Ltd reported revenue of ₹1,835 Cr in Q1 FY27, down 4.2% from ₹1,915 Cr in Q1 FY26 and up 66.7% from ₹1,101 Cr in Q4 FY26. It posted a net profit of ₹322 Cr for the quarter, against a net profit of ₹279 Cr in Q1 FY26 (up 15.4%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹1,046 Cr (Q4 FY25) to ₹1,915 Cr (Q1 FY26). The company was profitable in each of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹1,835 Cr₹322 Cr17.5%
Q4 FY26₹1,101 Cr₹162 Cr14.7%
Q3 FY26₹1,106 Cr₹96 Cr8.7%
Q2 FY26₹1,553 Cr₹153 Cr9.8%
Q1 FY26₹1,915 Cr₹279 Cr14.6%
Q4 FY25₹1,046 Cr₹143 Cr13.7%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 68.70% of Bayer Cropscience Ltd's shares as of Dec 2018, unchanged from Mar 2018. Delivery averaged 53.3% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Bayer Cropscience Ltd

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes row crop hybrid seeds. Further, it provides digital farming products comprising FarmRise and other digital applications, as well as tools, including remote sensing, IoT sensors, GPS, drones, artificial intelligence, and data analytics to monitor and manage crop growth, soil health, and weather conditions. The company also exports its products. Bayer CropScience Limited was founded in 1896 and is based in Thane, India.

Products and Services

1. Agri Care-This segment engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products, as well as corn seeds. 2. Healthcare-This segment offers non-agricultural pest control products, including vector and locust control, stored products protection, termite control, and rural hygiene, as well as housefly, cockroach, rodent, and mosquito control products primarily to pest control companies, government agencies, and other consumers. 3. Pesticides-This segment provides insecticides, fungicides, molluscicides, herbicides, and fertilizers. 4. Rubber-This segment engages in the manufacture and sale of rubber chemicals and other chemicals.

Business Segments

1. Agri Care-100%

Bayer Cropscience Ltd vs Peers — Crop Protection Chemicals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
United Phosphorus Ltd. (UPL)₹46,767 Cr24.85.61%₹11,860 Cr-25.2%
PI Industries Ltd₹26,436 Cr2012.35%₹1,702 Cr-54.4%
Sumitomo Chemicals India Ltd₹17,418 Cr32.817.24%₹907 Cr-27.1%
Bayer Cropscience Ltd₹15,609 Cr22.723.70%₹1,835 Cr-24.9%
Eid Parry India Ltd₹11,719 Cr219.91%₹11,213 Cr-36.1%
Sharda Cropchem Ltd₹6,457 Cr9.824.16%₹1,052 Cr-5.9%
Dhanuka Agritech Ltd₹4,049 Cr14.318.62%₹658 Cr-29.8%
Rallis India Ltd.₹3,680 Cr20.19.32%₹858 Cr-23.7%
Nacl Industries Ltd₹2,779 Cr566.40.82%₹374 Cr-37.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Bayer Cropscience Ltd?

Bayer Cropscience Ltd is trading at ₹3,450.00, with a market capitalisation of ₹15,609 Cr.

Which sector does Bayer Cropscience Ltd belong to?

Bayer Cropscience Ltd operates in the Materials > Chemicals > Fertilizers & Agri Chemicals space (Fertilizers and Agricultural Chemicals > Crop Protection Chemicals).

What are the key financial ratios of Bayer Cropscience Ltd?

Bayer Cropscience Ltd has a P/E of 22.7 and a return on equity of 23.70%.

What is the stock symbol of Bayer Cropscience Ltd?

Bayer Cropscience Ltd is listed on the BSE under the scrip code 506285.

How has Bayer Cropscience Ltd's share price moved over the past year?

Bayer Cropscience Ltd's share price is down 24.9% over one year and down 15.6% over three months. Its 52-week range is ₹3,226.10 to ₹5,063.00.

What were Bayer Cropscience Ltd's latest quarterly results?

In Q1 FY27, Bayer Cropscience Ltd reported revenue of ₹1,835 Cr and net profit of ₹322 Cr, with basic EPS of ₹71.56 (standalone, parsed from the company's exchange filing).

How have Bayer Cropscience Ltd's revenue and profit changed over the past year?

Bayer Cropscience Ltd reported revenue of ₹1,835 Cr in Q1 FY27, down 4.2% from ₹1,915 Cr in Q1 FY26 and up 66.7% from ₹1,101 Cr in Q4 FY26.

What is the promoter holding in Bayer Cropscience Ltd?

Promoters held 68.70% of Bayer Cropscience Ltd's shares as of Dec 2018, unchanged from Mar 2018.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.